Cargando…

Adipokines as Potential Biomarkers in Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a chronic systemic inflammatory autoimmune disease characterized by severe joint injury. Recently, research has been focusing on the possible identification of predictor markers of disease onset and/or progression, of joint damage, and of therapeutic response. Recent fin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Del Prete, Annalisa, Salvi, Valentina, Sozzani, Silvano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3985296/ https://www.ncbi.nlm.nih.gov/pubmed/24799765 http://dx.doi.org/10.1155/2014/425068

Ejemplares similares

Role of Atypical Chemokine Receptors in Microglial Activation and Polarization
por: Salvi, Valentina, et al.
Publicado: (2017)

Adipokines in Rheumatoid Arthritis: Emerging Biomarkers and Therapeutic Targets
por: Bilski, Jan, et al.
Publicado: (2023)

Dendritic cell subsets in cancer immunity and tumor antigen sensing
por: Del Prete, Annalisa, et al.
Publicado: (2023)

Functional Role of Dendritic Cell Subsets in Cancer Progression and Clinical Implications
por: Del Prete, Annalisa, et al.
Publicado: (2020)

CCRL2 Modulates Physiological and Pathological Angiogenesis During Retinal Development
por: Ben Dhaou, Cyrine, et al.
Publicado: (2021)

Adipokines and Autoimmunity in Inflammatory Arthritis
por: Neumann, Elena, et al.
Publicado: (2021)

Adipokines, inflammation, insulin resistance, and carotid atherosclerosis in patients with rheumatoid arthritis
por: Kang, Yoon, et al.
Publicado: (2013)

Insulin resistance and levels of adipokines in patients with untreated early rheumatoid arthritis
por: Manrique-Arija, Sara, et al.
Publicado: (2015)

Potential clinical biomarkers in rheumatoid arthritis with an omic approach
por: Puentes-Osorio, Yolima, et al.
Publicado: (2021)

Adiponectin Associates with Rheumatoid Arthritis Risk in Overweight and Obesity Independently of Other Adipokines
por: Zhang, Yuan, et al.
Publicado: (2021)

Response to ‘Adipokines, inflammation, insulin resistance, and carotid atherosclerosis in patients with rheumatoid arthritis’
por: Gonzalez-Gay, Miguel A, et al.
Publicado: (2014)

Adipokines as potential prognostic biomarkers in patients with acute knee injury
por: Kluzek, Stefan, et al.
Publicado: (2015)

Association of Apolipoprotein E Polymorphism with Adipokines and Cardiovascular Disease Risk in Rheumatoid Arthritis Patients
por: Chen, Yi-Ming, et al.
Publicado: (2020)

Association of the Adipokines Chemerin, Apelin, Vaspin and Omentin and Their Functional Genetic Variants with Rheumatoid Arthritis
por: Wahba, Alaa S., et al.
Publicado: (2021)

Adipokines and risk of rheumatoid arthritis: A two-sample multivariable Mendelian randomisation study
por: Vasileiadis, Georgios K., et al.
Publicado: (2023)

Cytokines as Biomarkers in Rheumatoid Arthritis
por: Burska, Agata, et al.
Publicado: (2014)

Fecal and Urinary Adipokines as Disease Biomarkers
por: Tews, Hauke C., et al.
Publicado: (2023)

Cytokine Targeting by miRNAs in Autoimmune Diseases
por: Salvi, Valentina, et al.
Publicado: (2019)

Adipokines and Inflammation Alter the Interaction Between Rheumatoid Arthritis Synovial Fibroblasts and Endothelial Cells
por: Hasseli, Rebecca, et al.
Publicado: (2020)

The Atypical Receptor CCRL2 (C-C Chemokine Receptor-Like 2) Does Not Act As a Decoy Receptor in Endothelial Cells
por: Mazzotti, Chiara, et al.
Publicado: (2017)

Molecular Basis for CCRL2 Regulation of Leukocyte Migration
por: Schioppa, Tiziana, et al.
Publicado: (2020)

NK Cell Anti-Tumor Surveillance in a Myeloid Cell-Shaped Environment
por: Russo, Eleonora, et al.
Publicado: (2021)

Effects of One-Year Tofacitinib Therapy on Lipids and Adipokines in Association with Vascular Pathophysiology in Rheumatoid Arthritis
por: Czókolyová, Monika, et al.
Publicado: (2022)

Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics
por: Conti, Valeria, et al.
Publicado: (2020)

Serum Adipokines and Adipose Tissue Distribution in Rheumatoid Arthritis and Ankylosing Spondylitis. A Comparative Study
por: Toussirot, Éric, et al.
Publicado: (2013)

Assessment of Adipokines, CXCL16 Chemokine Levels in Patients With Rheumatoid Arthritis Combined With Metabolic Syndrome
por: Turgunova, Lyudmila Gennadyevna, et al.
Publicado: (2021)

Usefulness of the Adipokines as Biomarkers of Ischemic Cardiac Dysfunction
por: Mocan Hognogi, Larisa-Diana, et al.
Publicado: (2018)

The PDE4 Inhibitor Tanimilast Blunts Proinflammatory Dendritic Cell Activation by SARS-CoV-2 ssRNAs
por: Nguyen, Hoang Oanh, et al.
Publicado: (2022)

Smoking Functions as a Negative Regulator of IGF1 and Impairs Adipokine Network in Patients with Rheumatoid Arthritis
por: Erlandsson, Malin C., et al.
Publicado: (2016)

Biomarkers in Rheumatoid Arthritis
por: Goëb, Vincent, et al.
Publicado: (2014)

Biomarkers in Rheumatoid Arthritis
por: Shapiro, Samantha C
Publicado: (2021)

Future Biomarkers for Infection and Inflammation in Rheumatoid Arthritis
por: Cui, Shuang, et al.
Publicado: (2023)

Identification of potential ferroptosis-associated biomarkers in rheumatoid arthritis
por: He, Xu, et al.
Publicado: (2023)

The Role of Adipokines as Circulating Biomarkers in Critical Illness and Sepsis
por: Loosen, Sven H., et al.
Publicado: (2019)

Adipokines as Biomarkers in Health and Disease
por: Bienertova-Vasku, Julie, et al.
Publicado: (2018)

The PDE4 inhibitor tanimilast shows distinct immunomodulatory properties associated with a type 2 endotype and CD141 upregulation
por: Nguyen, Hoang Oanh, et al.
Publicado: (2022)

Adiposity Measures and Plasma Adipokines in Females with Rheumatoid and Osteoarthritis
por: DeClercq, Vanessa, et al.
Publicado: (2017)

Effects of Tocilizumab, an Anti-Interleukin-6 Receptor Antibody, on Serum Lipid and Adipokine Levels in Patients with Rheumatoid Arthritis
por: Hoffman, Elinoar, et al.
Publicado: (2019)

Adipokines as potential biomarkers for type 2 diabetes mellitus in cats
por: Sierawska, Olga, et al.
Publicado: (2022)

TLR Signalling Pathways Diverge in Their Ability to Induce PGE(2)
por: Salvi, Valentina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tedp4dq0kcq9pil04ci061s7ej